An update on the genetics of HLA B27-associated acute anterior uveitis

Ocular Immunology and Inflammation

Volumn 19, Issue 2, 2011, Pages 108-114

  Martin, Tammy M ^a,b   Rosenbaum, James T ^a  

^a Science University   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

genetics; HLA; polymorphisms; spondyloarthropathy; uveitis

Indexed keywords

HLA A2 ANTIGEN; HLA B27 ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 23 RECEPTOR; PROTEIN HLA DRB1; STAT3 PROTEIN; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ARTICLE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA SEQUENCE; ENTERITIS; GENE LOCUS; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; HYPOPYON; IRIDOCYCLITIS; KIR GENE; MUTATOR GENE; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; SPONDYLOARTHROPATHY;

ACUTE DISEASE; ANIMALS; CHROMOSOME MAPPING; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HLA-B27 ANTIGEN; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; SPONDYLARTHROPATHIES; UVEITIS, ANTERIOR; WORLD HEALTH;

EID: 79953089433     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273948.2011.559302     Document Type: Article

References (95)

1. Brewerton DA, Caffrey M, Nicholls A, Walters D, James DC Acute anterior uveitis and HL-A 27. Lancet. 1973;2:994-996.
2. Caffrey M, Brewerton DA, Hart FD, James DC Human lymphocyte antigens as a possible diagnostic aid in ankylosing spondylitis. J Clin Pathol. 1973;26:387.
3. Caffrey MF, James DC Human lymphocyte antigen association in ankylosing spondylitis. Nature. 1973;242:121.
4. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med. 1973;288:704-706.
5. Brewerton DA, Nicholls A, Oates JK, Caffrey M, Walters D, James DCO. Reiter's Disease and HL-A 27. The Lancet. 1973;302:996-998.
6. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet. 1973;1:904-907.
7. Chang JH, Wakefeld D. Uveitis: A global perspective. Ocul Immunol Infamm. 2002;10:263.
8. Monnet D, Breban M, Hudry C, Dougados M, Brezin AP. Ophthalmic fndings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology 2004;111:802-809. (Pubitemid 38429680)
9. Tay-Kearney ML, Schwam BL, Lowder C, et al. Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol. 1996;121:47-56. (Pubitemid 26026080)
10. Chung Y, Liao H, Lin K, et al. Prevalence of spondyloarthritis in 504 chinese patients with HLA-B27-associated acute anterior uveitis. Scand J Rheumatol. 2009;38:84-90.
11. Rudwaleit M. New approaches to diagnosis and classifcation of axial and peripheral spondyloarthritis. Curr Opin Rheumatol. 2010;22:375-380.
12. Taurog JD, Richardson JA, Croft JT, et al. The germfree state prevents development of gut and joint infammatory disease in HLA-B27 transgenic rats. J Exp Med. 1994;180:2359-2364. (Pubitemid 24351619)
13. Khan MA. Remarkable polymorphism of HLA-B27: An ongoing saga. Curr Rheumatol Rep. 2010;12:337-341.
14. Reveille JD. Major histocompatibility genes and ankylosing spondylitis. Best Practice Res Clin Rheumatol. 2006;20:601-609. (Pubitemid 43869449)
15. Jaakkola E, Herzberg I, Laiho K, et al. Finnish HLA studies confrm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis. 2006;65:775-780. (Pubitemid 43799177)
16. Park SC, Ham D. Clinical features and prognosis of HLA-B27 positive and negative anterior uveitis in a korean population. J Korean Med Sci. 2009;24:722-728.
17. Tuncer S, Adam YS, Urgancioglu M, Tugal-Tutkun I. Clinical features and outcomes of HLA-B27-positive and HLA-B27-negative acute anterior uveitis in a turkish patient population. Ocul Immunol Infamm. 2005;13:367-373. (Pubitemid 41702760)
18. Rothova A, van Veenedaal WG, Linssen A, Glasius E, Kijlstra A, de Jong PT. Clinical features of acute anterior uveitis. Am J Ophthalmol. 1987;103:137-145. (Pubitemid 17005476)
19. Keino H, Sakai J, Usui M. Association between HLA-A2 in Japanese psoriasis arthritis and susceptibility to uveitis. Graefes Arch Clin Exp Ophthalmol. 2003;241:777-778. (Pubitemid 37265822)
20. Orchard TR, Chua CN, Ahmad T, Cheng H, Welsh KI, Jewell DP Uveitis and erythema nodosum in infammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology. 2002;123:714-718. (Pubitemid 34977077)
21. Monowarul Islam SM, Numaga J, Fujino Y, et al. HLA-DR8 and acute anterior uveitis in ankylosing spondylitis. Arthritis Rheum. 1995;38:547-550.
22. Ploski R, Flato B, Vinje O, Maksymowych W, Forre O, Thorsby E. Association to HLA-DRB1*08, HLA-DPB1*0301 and homozygosity for an HLA-linked proteasome gene in juvenile ankylosing spondylitis. Hum Immunol. 1995;44:88-96.
23. Maksymowych WP, Gorodezky C, Olivo A, et al. HLA-DRB1*08 infuences the development of disease in mexican mestizo with spondyloarthropathy J Rheumatol. 1997;24:904-907. (Pubitemid 27223625)
24. Maksymowych WP, Tao S, Vaile J, Suarez-Almazor M, Ramos-Remus C, Russell AS. LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative caucasian and mexican mestizo patients with ankylosing spondylitis. J Rheumatol. 2000;27:183-189. (Pubitemid 30058648)
25. Mackensen F, Reveille JD, Smith JR, et al. The MHC class II haplotype HLA-DRB1*0801/DQA1*0401/DQB1*0402 is associated with acute anterior uveitis. Invest Ophthalmol Vis Sci. 2005;46:3480.
26. Alaez C, Arellanes L, Vazquez A, et al. Classic pars planitis: strong correlation of class II genes with gender and some clinical features in mexican mestizos. Hum Immunol. 2003;64:965-972. (Pubitemid 37210848)
27. Mackensen F, David F, Schwenger V, et al. HLA-DRB1*0102 is associated with TINU syndrome and bilateral, suddenonset anterior uveitis but not with interstitial nephritis alone. Br J Ophthalmol. [Epub ahead of print] doi:10.1136/bjo.2010.187955
28. Sanchez-Burson J, Garcia-Porrua C, Montero-Granados R, Gonzalez-Escribano F, Gonzalez-Gay M,A. Tubulointerstitial nephritis and uveitis syndrome in southern spain. Semin Arthritis Rheum. 2002;32:125-129. (Pubitemid 35351247)
29. Howarth L, Gilbert RD, Bass P, Deshpande PV. Tubulointerstitial nephritis and uveitis in monozygotic twin boys. Pediatr Nephrol. 2004;19:917-919. (Pubitemid 39144778)
30. Li JY, Yong TY, Bennett G, Barbara JA, Coates PTH. Human leucocyte antigen DQ alpha heterodimers and human leu-cocyte antigen DR alleles in tubulointerstitial nephritis and uveitis syndrome. Nephrology. 2008;13:755-757.
31. Levinson RD, Park MS, Rikkers SM, et al. Strong associa-tions between specifc HLA-DQ and HLA-DR alleles and the tubulointerstitial nephritis and uveitis syndrome. Invest Ophthalmol Visual Sci. 2003;44:653-657. (Pubitemid 36159711)
32. Levinson RD, See RF, Rajalingam R, et al. HLA-DRB1 and-DQB1 alleles in mestizo patients with Vogt-Koyanagi-Harada's disease in Southern California. Hum Immunol. 2004;65:1477-1482. (Pubitemid 39643229)
33. Alaez C, del Pilar Mora M, Arellanes L, et al. Strong association of HLA class II sequences in mexicans with Vogt-Koyanagi-Harada's disease. Hum Immunol. 1999;60:875-882. (Pubitemid 29476777)
34. Soto-Vega E, Garcia-Munoz R, Richaud-Patin Y, et al. Class I and class II MHC polymorphisms in Mexican patients with Behcet's disease. Immunol Lett. 2004;93:211-215. (Pubitemid 38670376)
35. Mizuki N, Ota M, Yabuki K, et al. Localization of the patho-genic gene of behcet's disease by microsatellite analysis of three different populations. Invest Ophthalmol Vis Sci. 2000;41:3702-3708.
36. de Menthon M, LaValley MP, Maldini C, Guillevin L, Mahr A. HLA-B51/B5 and the risk of behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Care Res. 2009;61:1287-1296.
37. Goto K, Ota M, Maksymowych WP, et al. Association between MICA gene A4 allele and acute anterior uveitis in white patients with and without HLA-B27. Am J Ophthalmol. 1998;126:436-441. (Pubitemid 28422070)
38. Goto K, Ota M, Ando H, et al. MICA gene polymorphisms and HLA-B27 subtypes in japanese patients with HLA-B27-associated acute anterior uveitis. Invest Ophthalmol Vis Sci. 1998;39:634-637. (Pubitemid 28110698)
39. Martinez-Borra J, Gonzalez S, López-Vazquez A, et al. HLA-B27 alone rather than B27-related class I haplotypes contrib-utes to ankylosing spondylitis susceptibility Hum Immunol. 2000;61:131-139. (Pubitemid 30075234)
40. Choy M, Phipps ME. MICA polymorphism: biology and importance in immunity and disease. Trends Mol Med. 2010;16:97-106.
41. Maksymowych WP, Wessler A, Schmitt-Egenolf M, et al. Polymorphism in an HLA linked proteasome gene infu-ences phenotypic expression of disease in HLA-B27 positive individuals. J Rheumatol. 1994;21:665-669. (Pubitemid 24126762)
42. Maksymowych WP, Suarez-Almazor M, Chou CT, Russell AS. Polymorphism in the LMP2 gene infuences susceptibility to extraspinal disease in HLA-B27 positive individuals with ankylosing spondylitis. Ann Rheum Dis. 1995;54:321-324.
43. Maksymowych WP, Russell AS. Polymorphism in the LMP2 gene infuences the relative risk for acute anterior uveitis in unselected patients with ankylosing spondylitis. Clin Invest Med. 1995;18:42-46.
44. Maksymowych WP, Jhangri GS, Gorodezky C, et al. The LMP2 polymorphism is associated with susceptibility to acute anterior uveitis in HLA-B27 positive juvenile and adult mexican subjects with ankylosing spondylitis. Ann Rheum Dis. 1997;56:488-492. (Pubitemid 27396036)
45. Burney RO, Pile KD, Gibson K, et al. Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis. Ann Rheum Dis. 1994;53:58-60. (Pubitemid 24067411)
46. Hohler T, Schaper T, Schneider PM, et al. No primary association between LMP2 polymorphisms and extraspinal manifestations in spondyloarthropathies. Ann Rheum Dis. 1997;56:741-743. (Pubitemid 28064841)
47. Konno Y, Numaga J, Mochizuki M, Mitsui H, Hirata R, Maeda H. TAP polymorphism is not associated with ankylosing spondylitis and complications with acute anterior uveitis in HLA-B27-positive japanese. Tissue Antigens. 1998;52:478-483. (Pubitemid 28521621)
48. Touma Z, Farra C, Hamdan A, et al. TNF polymorphisms in patients with behçet disease: a meta-analysis. Arch Med Res. 2010;41:142-146.
49. El-Shabrawi Y, Wegscheider BJ, Weger M, et al. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations. Ophthalmology. 2006;113:695-700.
50. Kuo NW, Lympany PA, Menezo V, et al. TNF-857T, a genetic risk marker for acute anterior uveitis. Invest Ophthalmol Vis Sci. 2005;46:1565-1571. (Pubitemid 44843587)
51. Menezo V, Bond SK, Towler HM, et al. Cytokine gene polymorphisms involved in chronicity and complications of anterior uveitis. Cytokine. 2006;35:200-6. (Pubitemid 44696305)
52. Kulkarni S, Martin MP, Carrington M. The yin and yang of HLA and KIR in human disease. Semin Immunol. 2008;20:343-352.
53. Levinson RD, Okada AA, Ashouri E, Keino H, Rajalingam R. Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to VogtKoyanagi-Harada syndrome in Japanese individuals. Hum Immunol. 2010;71:192-194.
54. Levinson RD, Martin TM, Luo L, et al. Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy Invest Ophthalmol Vis Sci. 2010;51:1505-1510.
55. Levinson RD, Du Z, Luo L, et al. KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease. Hum Immunol. 2008;69:349-353.
56. Levinson RD, Du Z, Luo L, et al. Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals. Genes Immun. 2008;9:249-258. (Pubitemid 351584191)
57. Middleton D, Meenagh A, Sleator C, et al. No association of KIR genes with behcet's disease. Tissue Antigens. 2007;70:435-438. (Pubitemid 47537408)
58. Seo J, Park JS, Nam JH, et al. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with behcet's disease. Tissue Antigens. 2007;70:307-313. (Pubitemid 47340735)
59. Arayssi TK, El Hajj N, Shamseddine W, et al. Killer cell immunoglobulin-like receptor genotypes in behcet's disease patients: any role for the 3DP1*001/002 pseudogene? Genet Test Mol Biomarkers. 2009;13:319-324.
60. Zvyagin IV, Mamedov IZ, Britanova OV, et al. Contribution of functional KIR3DL1 to ankylosing spondylitis. Cell Mol Immunol. 2010;7:471-476.
61. Diaz-Pena R, Blanco-Gelaz MA, Suarez-Alvarez B, et al. Activating KIR genes are associated with ankylosing spondylitis in asian populations. Hum. Immunol. 2008;69:437-442.
62. Diaz-Pena R, Vidal-Castineira JR, Alonso-Arias R, et al. Association of the KIR3DS1*013 and KIR3DL1*004 alleles with susceptibility to ankylosing spondylitis. Arthritis Rheum. 2010;62:1000-1006.
63. Harvey D, Pointon JJ, Sleator C, et al. Analysis of killer immunoglobulin-like receptor genes in ankylosing spondylitis. Ann Rheum Dis. 2009;68:595-598.
64. Jiao YL, Ma CY, Wang LC, et al. Polymorphisms of KIRs gene and HLA-C alleles in patients with ankylosing spondylitis: possible association with susceptibility to the disease. J Clin Immunol. 2008;28:343-349.
65. Jiao YL, Zhang BC, You L, et al. Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis. J Clin Immunol. 2010;30:840-844.
66. Lopez-Larrea C, Blanco-Gelaz MA, Torre-Alonso JC, et al. Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 caucasian populations. Arthritis Res Ther. 2006;8:R101.
67. Mousavi T, Poormoghim H, Moradi M, Tajik N, Shahsavar F, Asadifar B. Inhibitory killer cell immunoglobulin-like receptor KIR3DL1 in combination with HLA-B Bw4iso protect against ankylosing spondylitis. Iran J Immunol. 2010;7:88-95.
68. Zhang BC, Liu Y, Jiao YL, Zhao YR, Li JF. Genotype and haplotype analysis of killer cell immunoglobulin-like recep-tors in ankylosing spondylitis]. Zhonghua Yi Xue Za Zhi. 2009;89:91-95.
69. Atan D, Fraser-Bell S, Plskova J, et al. Cytokine polymorphism in noninfectious uveitis. Invest Ophthalmol Vis Sci. 2010;51:4133-4142.
70. Wallace GR, Kondeatis E, Vaughan RW, et al. IL-10 genotype analysis in patients with Behcet's disease. Hum Immunol. 2007;68:122-127. (Pubitemid 46282216)
71. Dilek K, Ozcimen AA, Saricaoglu H, et al. Cytokine gene polymorphisms in Behcet's disease and their association with clinical and laboratory fndings. Clin Exp Rheumatol. 2009;27:S73-S78.
72. Stanford MR, Vaughan RW, Kondeatis E, et al. Are cytokine gene polymorphisms associated with outcome in patients with idiopathic intermediate uveitis in the united kingdom? Br J Ophthalmol. 2005;89:1013-6. (Pubitemid 41081415)
73. Atan D, Turner SJ, Kilmartin DJ, et al. Cytokine gene poly-morphism in sympathetic ophthalmia. Invest Ophthalmol Vis Sci 2005;46:4245-4250. (Pubitemid 44264628)
74. Glover N, Ah-Chan JJ, Frith P, Downes S, Atan D. Unremitting sympathetic ophthalmia associated with homozygous interleukin-10-1082A single nucleotide polymorphism. Br J Ophthalmol. 2008;92:155-156.
75. Brown MA. Genetics of ankylosing spondylitis. Curr Opin Rheumatol. 2010;22:126-132.
76. Thomas GP, Brown MA. Genetics and genomics of ankylos-ing spondylitis. Immunol Rev. 2010;233:162-180.
77. Australo-Anglo-American Spondyloarthritis Consortium (TASC), Reveille JD, Sims AM, et al. Genome-wide associa-tion study of ankylosing spondylitis identifes non-MHC susceptibility loci. Nat Genet. 2010;42:123-127.
78. Wellcome Trust Case Control Consortium, Australo-Anglo-American Spondylitis Consortium (TASC), Burton PR, et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifes autoimmunity variants. Nat Genet. 2007;39:1329-1337. (Pubitemid 350041542)
79. Duan Z, Pan F, Zeng Z, et al. Interleukin-23 receptor genetic polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. Rheumatol Int. 2011. [Epub ahead of print] doi:10.1007/s00296-010-1769-7
80. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifes IL23R as an infammatory bowel disease gene. Science 2006; 314: 1461-1463. (Pubitemid 44871953)
81. Dubinsky MC, Wang D, Picornell Y, et al. IL-23 receptor (IL-23R) gene protects against pediatric crohn's disease. Infamm Bowel Dis. 2007;13:511-515. (Pubitemid 46799633)
82. Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic association study confrms IL12B and leads to the identifcation of IL23R as psoriasis-risk genes. Am J Hum Genet. 2007;80:273-290. (Pubitemid 46175676)
83. Rahman P, Inman RD, Maksymowych WP, Reeve JP, Peddle L, Gladman DD. Association of interleukin 23 receptor variants with psoriatic arthritis. J Rheumatol. 2009;36:137-140.
84. Martin TM, Smith JR, Doyle TM, et al. The interleukin-23 receptor is a new susceptibility gene for acute anterior uveitis. Invest Ophthalmol Vis Sci. 2008;49:3236.
85. Jiang Z, Yang P, Hou S, et al. IL-23R gene confers susceptibility to Behcet's disease in a Chinese Han population. Ann Rheum Dis. 2010;69:1325-1328.
86. Mizuki N, Meguro A, Ota M, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as behcet's disease susceptibility loci. Nat Genet. 2010;42:703-706.
87. Remmers EF, Cosan F, Kirino Y, et al. Genome-wide association study identifes variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with behcet's disease. Nat Genet. 2010;42:698-702.
88. Laval SH, Timms A, Edwards S, et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC geneticsusceptibility loci. Am J Hum Genet. 2001;68:918-926. (Pubitemid 32289738)
89. Brown MA, Pile KD, Kennedy LG, et al. A genome-wide screen for susceptibility loci in ankylosing spondylitis. Arthritis Rheum. 1998;41:588-595. (Pubitemid 28214976)
90. Zhang G, Luo J, Bruckel J, et al. Genetic studies in familial ankylosing spondylitis susceptibility Arthritis Rheum. 2004;50:2246-2254. (Pubitemid 38924403)
91. Chandran V Rahman P. Update on the genetics of spondyloarthritis- ankylosing spondylitis and psoriatic arthritis. Best Practice Res Clin Rheumatol. 2010;24:579-588.
92. Martin TM, Zhang G, Luo J, et al. A locus on chromosome 9p predisposes to a specifc disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, infammatory disease. Arthritis Rheumat. 2005;52:269-274. (Pubitemid 40129257)
93. Martin TM, Evans DM, Danoy P, et al. Genomewide scan in acute anterior uveitis: similarities and differences with genes associated with ankylosing spondylitis [abstract]. Arthritis Rheum. 2009;60 (Suppl 10):1231.
94. Glocker E, Hennigs A, Nabavi M, et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med. 2009;361:1727-1735.
95. Ruutu M, Yadav B, Thomas G, et al. Fungal beta-glucan triggers spondyloarthropathy and Crohn's disease in SKG mice. [abstract] Arthritis Rheum. 2010;62 (Suppl 10):1446.